drugset / Trial / NCT02494284
Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation
Phase 4
Terminated
364 enrolled
CHEOL WHAN LEE, M.D., Ph.D
CardioVascular Research Foundation, Korea · collabChong Kun Dang Pharmaceutical · collabMedtronic · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare short-term (6-month Dual Anti Platelet Therapy(DAPT) followed by clopidogrel monotherapy) vs. standard long-term dual antiplatelet strategies (24-month DAPT followed by aspirin monotherapy) on clinically relevant bleeding complications (Bleeding Academic Research Consortium(BARC) type 2, 3, or 5)31 in patients after zotarolimus-eluting stent implantation.
Timeline
- Start
- 2015-12-22
- Primary completion
- 2017-02-13
- Completion
- 2017-02-13
Outcome
Outcome not reported
Stopped (Enrollment): “Slow enrollment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | — | — |
| Comparator | Clopidogrel | Small molecule | — | — |